Quantitation of Glandular Gastric Changes in Rats Given a Proton Pump Inhibitor for 3 Months with Emphasis on Sampling Scheme Selection

Abstract

Proton pump inhibitors and H2-receptor antagonists suppress gastric acid secretion and secondarily induce hypergastrinemia. Sustained hypergastrinemia has a trophic effect on stomach fundic mucosa, including enterochromaffin-like (ECL) cell hypertrophy and hyperplasia. Histomorphometric quantitation of the pharmacologic gastric effects was conducted on 10 male and 10 female rats treated orally with LY307640 sodium, a proton pump inhibitor, at daily doses of 25, 60, 130, or 300 mg/kg for 3 mo. Histologic sections of glandular stomach, stained for chromogranin A, were evaluated by image analysis to determine stomach mucosal thickness, mucosal and nonmucosal (submucosa and muscularis) area, gastric glandular area, ECL cell number/area and cross-sectional area. Total mucosal and nonmucosal tissue volumes per animal were derived from glandular stomach volumetric and area data. Daily oral doses of compound LY307640 sodium caused slight to moderate dose-related mucosal hypertrophy and ECL cell hypertrophy and hyperplasia in all treatment groups as compared with controls. AU observed effects were prominent in both sexes but were generally greater in females. The morphometric sampling schemes were explored to optimize the data collection efficiency for future studies. A comparison between the sampling schemes used in this study and alternative schemes was conducted by estimating the probability of detecting a specific percentage of change between the male control and high-dose groups based on Tukey's trend test. The sampling scheme analysis indicated that mucosal thickness and mass had been oversampled. ECL cell density quantitation efficiency would have been increased by sampling the basal mucosa only for short-term studies. The ECL cell size sampling scheme was deemed appropriate for this type of study.

Keywords

LY307640 sodium morphometry image analysis stomach enterochromaffin-like cell chromogranin A

References

1. Betton GR , Dormer CS , Wells T , Pert R Price CA , and Buckley p (1988). Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole. Toxicol. Pathol. 16: 288–298.

2. Creutzfeldt W , Stockmann F , Conlon JM , Folsch UR , Bonatz G , and Wulfrath M (1986). Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion 35: 84–97.

3. Ekman L , Hansson E , Havu N , Carlsson E , Lundberg, C (1985). Toxicological studies on omeprazole. Scand. J. Gastroenterol. 20(suppl. 108): 53–69.

4. Gundersen HJG and Osterby R (1981). Optimizng sampling efficiency of steriological studies in biology or “Do more less well!” J. Microsc. 121: 65–73.

5. Hakanson R , Tielemans Y , Chen D , Andersson K , Ryberg B , Matts-son H , and Sundler F (1992). The biology and pathobiology of the ECL cells. Yale J. Biol. Med. 65: 761–774.

6. Havu N (1986). Enterochromaffin-like cells carcinoids of gastric mucosa in rats after life-longinhibition of gastric secretion. Digestion 35(suppl. 1): 42–55.

7. Larsson H , Hakanson R , Mattsson H , Ryberg B , Sundler F , and Carlsson E (1988). Omeprazole: Its influence on gastric acid secretion, gastrin and ECL cells. Toxicol. Pathol. 16: 267–272.

8. Morii M and Takeguchi N (1993). Different biochemical modes of action of two irreversible H+,K+-ATPase inhibitors, omeprazole and E3810. J. Biol. Chem. 268: 21553–21559.

9. Rohr I and Tuch K (1992). Effects of short-term treatment with an H+K+-ATPase inhibitor (B8301-O78) on enterochromaffin-like (ECL) cells in rat fundic mucosa. Toxicol. Pathol. 20: 141–145.

10.

10. SAS Institute (1989). The GLM procedure. In SAS/STAT User's Guide, Version 6, Vol. 2, 4th ed. SAS Institute, Cary, North Carolina, pp. 891–996.

11.

11. Scherle W (1970). A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26: 57–60.

12.

12. Tuch K , Ockert D , Hauschke D , and Christ B (1992). Comparison of the ECL-cell frequency in the stomachs of 3 different rat strains. Pathol. Res. Pract. 188: 672–675.

13.

13. Tukey JW , Caminera JL , and Heyse JF (1985). Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 41: 295–301.

14.

14. Weibel ER (1979). Stereological Methods, Practical Methods for Biological Morphometry, Vol. 1. Academic Press, Orlando, Florida, p. 157.